MENU
+Compare
QGEN
Stock ticker: NYSE
AS OF
Feb 4, 11:19 AM (EDT)
Price
$51.80
Change
-$0.09 (-0.17%)
Capitalization
10.69B

QGEN Qiagen NV Forecast, Technical & Fundamental Analysis

Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins... Show more

QGEN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for QGEN with price predictions
Feb 03, 2026

QGEN saw its Stochastic Oscillator recovers from the overbought zone

The Stochastic Oscillator for QGEN moved out of overbought territory on January 28, 2026. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 63 similar instances where the indicator exited the overbought zone. In of the 63 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for QGEN moved out of overbought territory on January 26, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on February 03, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on QGEN as a result. In of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for QGEN turned negative on February 03, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where QGEN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

QGEN broke above its upper Bollinger Band on January 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

QGEN moved above its 50-day moving average on January 05, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for QGEN crossed bullishly above the 50-day moving average on January 07, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

The 50-day moving average for QGEN moved above the 200-day moving average on January 16, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where QGEN advanced for three days, in of 290 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 182 cases where QGEN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.929) is normal, around the industry mean (12.114). P/E Ratio (26.638) is within average values for comparable stocks, (121.202). Projected Growth (PEG Ratio) (0.347) is also within normal values, averaging (1.874). Dividend Yield (0.005) settles around the average of (0.016) among similar stocks. P/S Ratio (5.133) is also within normal values, averaging (12.571).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. QGEN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. QGEN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
QGEN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

QGEN is expected to report earnings to rise 1.18% to 61 cents per share on February 04

Qiagen NV QGEN Stock Earnings Reports
Q4'25
Est.
$0.62
Q3'25
Beat
by $0.02
Q2'25
Est.
$0.60
Q1'25
Beat
by $0.06
Q4'24
Beat
by $0.01
The last earnings report on November 04 showed earnings per share of 61 cents, beating the estimate of 58 cents. With 2.84M shares outstanding, the current market capitalization sits at 10.69B.
A.I. Advisor
published General Information

General Information

a manufacturer of sample and assay technology products for preanalytical sample preparations

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
Hulsterweg 82
Phone
+31 773556600
Employees
6000
Web
https://www.qiagen.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SDEM32.830.23
+0.70%
Global X MSCI SuperDividend® Em Mkts ETF
CPSP26.20N/A
N/A
CALAMOS S&P 500 STRUCTURED ALT PROTECTION ETF - APRIL
DHSB26.03-0.07
-0.26%
Day Hagan Smart Buffer ETF
BUFQ35.99-0.25
-0.69%
FT Vest Laddered Nasdaq Buffer ETF
INCO63.11-0.50
-0.79%
Columbia India Consumer ETF

QGEN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, QGEN has been loosely correlated with BRKR. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if QGEN jumps, then BRKR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QGEN
1D Price
Change %
QGEN100%
-2.78%
BRKR - QGEN
58%
Loosely correlated
-1.22%
BIO - QGEN
54%
Loosely correlated
+1.27%
TMO - QGEN
50%
Loosely correlated
+0.55%
RVTY - QGEN
50%
Loosely correlated
-1.57%
RGEN - QGEN
49%
Loosely correlated
+1.17%
More

Groups containing QGEN

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QGEN
1D Price
Change %
QGEN100%
-2.78%
QGEN
(2 stocks)
75%
Closely correlated
-1.80%